TrialsgrambetaRCTs are beautiful

PARAMEDIC2

2018

Adrenaline versus Placebo in Out-of-Hospital Cardiac Arrest

In 8,014 adults with OHCA, 1 mg intravenous adrenaline increased 30-day survival versus placebo, without improving favourable neurologic survival.

Result

Efficacy: 30-day survivalOR 1.39 · P = 0.02

Below 1 favours placebo, above 1 favours 1 mg intravenous adrenaline.

Event rates
Absolute difference
0.8 points
NNT
125

Absolute difference and NNT are derived from the event rates.

Also reported: Favourable neurologic survival 2.2% vs 1.9% (NS).

Original publication
Subtopic
Adrenaline
Design
Double-blind RCT, UK
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Also listed in
Cardiac arrest & CPR
Source
Perkins GD, et al. N Engl J Med. 2018;379(8):711-721.doi 10.1056/NEJMoa1806842

Discussion & critique

Modest survival gain at the cost of more severe-disability survivors: central debate in resuscitation ethics.

Discussed in podcasts